Promising Results for Pain and Neuroprotection
2 Articles
Studies indicate that cannabinoids may significantly alleviate chronic pain and enhance neuroprotection, expanding cannabis use in medical care.
go to storyStories about Science
Using Cannabis Compounds to Improve Sleep
2 Articles
Cannabinoids like THC, CBD, and CBN show promise for improving sleep by interacting with the endocannabinoid system, but finding the right product and dose is crucial for avoiding unwanted side effects.
go to storyStudy Reveals CBN's Potential in Neuroprotection
2 Articles
Salk Institute researchers have discovered that CBN, a lesser-known cannabinoid with neuroprotective properties, could lead to future therapies for neurodegenerative diseases and brain injury prevention. The search for effective treatments for neurodegenerative diseases has long been a challenge, particularly as the global population ages and the prevalence of conditions like Alzheimer’s and Parkinson’s continues to rise. However, recent research from the Salk Institute offers a glimmer of hope, focusing on a lesser-known cannabinoid, cannabinol (CBN), and its potential to protect the brain against aging and neurodegeneration.
go to storyIntensified Dreams and Symptoms After Quitting
10 Articles
Unveiling marijuana withdrawal's multifaceted nature, this article explores its interplay with neurobiology, psychology, and treatment strategies for recovery.
go to storyRecently added Resources about Science
Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment
26min read
Despite the importance of pain as a warning physiological system, chronic neuropathic pain is frequently caused by damage in the nervous system, followed by persistence over a long period, even in the absence of dangerous stimuli or after healing of injuries.
go to story
Cannabis Treatment Reduces Chronic Nerve Pain With ‘Minimal To No Side Effects,’ New Scientific Review Finds
4min read
A newly published review of research on marijuana and chronic nerve pain concludes that treatment with cannabinoids offers “significant relief from chronic pain” with “minimal to no side effects”—potentially providing patients a “life-changing alternative” to conventional pharmaceuticals.
go to story
National Center for Biotechnology Information
Cannabis and Mood Disorders
17min read
The present review will provide an overview of the neurobiology, epidemiology, clinical impact, and treatment of cannabis use disorder (CUD) in mood disorders. Patients with mood disorders including major depressive disorder (MDD) and bipolar disorder (BD) have higher rates of cannabis use, and CUD compared to the general population. Reasons for this association are not clear, nor are the putative therapeutic effects of cannabis use, or its components delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), in these illnesses. The evidence surrounding treatments for patients with this comorbidity is lacking, with more support for psychotherapeutic treatments compared with pharmacological treatments.
go to story
Cannabis use and mood disorders: a systematic review
24min read
Problematic cannabis use is highly prevalent among people with mood disorders. This underscores the need to understand the effects of cannabis and cannabinoids in this population, especially considering legalization of recreational cannabis use.
go to story
Understanding Cannabis And Sleep: THC, CBD, And CBN Explained
3min read
Cannabis products are being used for sleep more frequently as cannabis legalization spreads. Learn more about cannabis and sleep here.
go to story
Fragment-based drug discovery and biological evaluation of novel cannabinol-based inhibitors of oxytosis/ferroptosis for neurological disorders
39min read
The oxytosis/ferroptosis regulated cell death pathway is an emerging field of research owing to its pathophysiological relevance to a wide range of neurological disorders, including Alzheimer's and Parkinson's diseases and traumatic brain injury.
go to story
